Brian C. Thomas sold $19k of MGX
Chief Executive Officer at Metagenomi, Inc.. 10,785 shares at an average of $1.75, traded Jun 6, 2025, filed Jun 9, 2025.
Score components
- +25RoleCEO
- 0Trade size$19k at market
- 0Share of holdings soldSold 0.4% of holdings
- +15Cluster5 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-083947, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 6, 2025 | SOpen-market sale Common Stock | -10,785 | $1.75 | $19k | 2,517,491 | Jun 9, 2025 |
Related signals
Other insiders at Metagenomi, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | MGXbuy Metagenomi, Inc. | Laurence Reid director | $23k 20,000 shares | - | |
| 30Weak | Metagenomi, Inc. | Jian Irish See Remarks | $2,479 2,140 shares | -1% | |
| 37Weak | Metagenomi, Inc. | Pamela Wapnick Chief Financial Officer | $2,214 1,911 shares | -1% | |
| 30Weak | Metagenomi, Inc. | Matthew Wein See Remarks | $415 358 shares | -0% | |
| 30Weak | Metagenomi, Inc. | Jian Irish See Remarks | $11k 6,390 shares | -2% | |
| 37Weak | Metagenomi, Inc. | Pamela Wapnick Chief Financial Officer | $2,758 1,576 shares | -2% | |
| 30Weak | Metagenomi, Inc. | Sarah B. Noonberg Chief Medical Officer | $9,168 5,239 shares | -5% | |
| 30Weak | Metagenomi, Inc. | Matthew Wein See Remarks | $348 199 shares | -1% | |
| 22Weak | MGXsell Metagenomi, Inc. | Pamela Wapnick Chief Financial Officer | $2,900 1,559 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.